Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Units: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,1,040,93,1,133,
%Companies according to biotechnology used: Genetic code,32,43,33,
%Companies according to biotechnology used: Functional units,40,51,41,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,22,41,24,
%Companies according to biotechnology used: Bioprocesses,48,69,50,
%Companies according to biotechnology used: Sub-cellular organisms,5,12,6,
%Companies according to biotechnology used: Bio-computing,24,28,24,
%Companies according to biotechnology used: Nanobiotechnology,13,13,13,
%Companies according to biotechnology used: Other,15,8,14,
Companies in which biotechnology activities are: Main and/or exclusive,581,22,603,
Companies in which biotechnology activities are: A secondary line of business,155,18,173,
Companies in which biotechnology activities are: A tool necessary for production,305,53,357,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,49,45,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,3,18,
%Company by field(s) of ultimate application of biotechnology use: Food products,30,39,31,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,17,22,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,17,14,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,9,12,
Personnel in R&D in biotechnology (no. of persons),8,124,3,386,11,510,
Personnel in R&D in biotechnology (no. of persons): Researchers,4,552,1,650,6,202,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3,572,1,736,5,308,
Personnel in R&D in biotechnology (no. of persons): women,4,363,2,026,6,389,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2,368,935,3,304,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1,995,1,090,3,086,
Personnel in R&D in biotechnology (FTE),5,788.1,2,448.9,8,236.9,
Personnel in R&D in biotechnology (FTE): Researchers,3,364.3,1,231.9,4,596.1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2,423.8,1,217.0,3,640.8,
Personnel in R&D in biotechnology (FTE): women,3,197.5,1,501.0,4,698.5,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1,803.7,708.8,2,512.5,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1,393.8,792.2,2,186.0,
Internal expenditure on R&D (thousands of euros),558,184,211,247,769,431,
1) By nature of the expense: Current expenses,518,032,201,684,719,715,
1.1) Remuneration to researchers,154,555,66,892,221,447,
1.2) Remuneration to technicians and assistants,72,617,50,192,122,809,
1.3) Other current expenses,290,860,84,599,375,459,
2) By nature of the expense: Capital expenses,40,152,9,563,49,715,
2.1) Land and buildings,6,661,2,860,9,521,
2.2) Equipment and instruments,24,465,6,001,30,466,
2.3) Acquisition of specific R&D software,1,157,653,1,810,
2.4) Otros productos de propiedad intelectual específicos para I+D,7,869,49,7,919,
1.1) By origin of the funds: Own funds,385,847,105,066,490,913,
1.2) By origin of the funds: From companies,53,140,29,409,82,548,
1.3) By origin of the funds: Public Administration funds,64,168,32,641,96,809,
1.4) By origin of the funds: From Universities,197,0,197,
1.5) By origin of the funds: From non profit private institutions,588,4,177,4,766,
1.6) By origin of the funds: Foreign funds,54,244,39,954,94,197,
Purchase of R&D services in biotechnology (thousands of euros),68,331,51,951,120,281,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,22,667,46,897,69,564,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,45,664,5,054,50,718,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,47,23,45,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,13,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,15,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,15,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,17,11,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,19,10,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,13,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,29,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,53,39,52,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,14,20,
% Companies that have requested biotechnology patents in Biotechnology,15,17,15,
Number of patents requested,525,156,681,
% Companies with income of an international origin related to biotechnological activities,24.9,18.4,24.3,
% Turnover representing income of an international origin related to biotechnological activities,6.00,1.00,1.00,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,45.20,73.10,59.60,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,54.80,26.90,40.40,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,89.00,72.50,80.40,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,7.50,24.90,16.50,
% Income of an international origin related with activities according to the classification: Operating source abroad,2.20,2.30,2.20,
% Income of an international origin related with activities according to the classification: Other,1.40,0.40,0.90,
Notes:
1) '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Source: National Statistics Institute